GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (OTCPK:RADLY) » Definitions » Current Ratio

Raia Drogasil (Raia Drogasil) Current Ratio : 1.43 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Raia Drogasil Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Raia Drogasil's current ratio for the quarter that ended in Mar. 2024 was 1.43.

Raia Drogasil has a current ratio of 1.43. It generally indicates good short-term financial strength.

The historical rank and industry rank for Raia Drogasil's Current Ratio or its related term are showing as below:

RADLY' s Current Ratio Range Over the Past 10 Years
Min: 1.31   Med: 1.54   Max: 1.87
Current: 1.43

During the past 13 years, Raia Drogasil's highest Current Ratio was 1.87. The lowest was 1.31. And the median was 1.54.

RADLY's Current Ratio is ranked better than
53.18% of 677 companies
in the Healthcare Providers & Services industry
Industry Median: 1.37 vs RADLY: 1.43

Raia Drogasil Current Ratio Historical Data

The historical data trend for Raia Drogasil's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil Current Ratio Chart

Raia Drogasil Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.41 1.46 1.31 1.50 1.43

Raia Drogasil Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.39 1.42 1.47 1.43 1.43

Competitive Comparison of Raia Drogasil's Current Ratio

For the Pharmaceutical Retailers subindustry, Raia Drogasil's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raia Drogasil's Current Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's Current Ratio distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's Current Ratio falls into.



Raia Drogasil Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Raia Drogasil's Current Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Current Ratio (A: Dec. 2023 )=Total Current Assets (A: Dec. 2023 )/Total Current Liabilities (A: Dec. 2023 )
=2359.622/1648.944
=1.43

Raia Drogasil's Current Ratio for the quarter that ended in Mar. 2024 is calculated as

Current Ratio (Q: Mar. 2024 )=Total Current Assets (Q: Mar. 2024 )/Total Current Liabilities (Q: Mar. 2024 )
=2415.409/1684.081
=1.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Raia Drogasil  (OTCPK:RADLY) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Raia Drogasil Current Ratio Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Raia Drogasil (Raia Drogasil) Business Description

Traded in Other Exchanges
Address
Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000
Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.

Raia Drogasil (Raia Drogasil) Headlines

From GuruFocus

Q4 2021 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2022 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2019 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2020 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Raia Drogasil SA Day Transcript

By GuruFocus Research 02-14-2024

Q3 2020 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2021 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2022 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2019 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2023 Raia Drogasil SA Earnings Call Transcript

By GuruFocus Research 02-14-2024